Serum CA19-9 as a marker of circulating tumor cells in first reflux blood of colorectal cancer patients

Circulating tumor cells (CTCs) are used for metastasis surveillance in cancer patients, but low detection rates limit their use in colorectal cancer (CRC). We investigated the distribution of CTCs in peripheral and portal blood of CRC patients, and analyzed the relationship between serum tumor CEA/C...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jia-Xing, Liu, Li-Ren, Yang, Xiao-Yu, Liu, Fang, Zhang, Zhong-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620224/
https://www.ncbi.nlm.nih.gov/pubmed/28978084
http://dx.doi.org/10.18632/oncotarget.18912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620224/
https://www.ncbi.nlm.nih.gov/pubmed/28978084
http://dx.doi.org/10.18632/oncotarget.18912

Ejemplares similares